SCHEMBL95280

SCHEMBL95280

CON(C(C)=O)C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14446889 0.82 ALDH1A1 (0.40)
SCHEMBL18790945 0.78 ALDH1A1 (0.35)
SCHEMBL6796242 0.69
SCHEMBL218587 0.69
SCHEMBL133026 0.69 NQO1 (0.41)
SCHEMBL8893309 0.69
SCHEMBL18772465 0.67
SCHEMBL218586 0.67
SCHEMBL22957158 0.67 NQO1 (0.34)
SCHEMBL22566417 0.65 SOAT1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150390-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE DAIICHI SANKYO COMPANY, LIMITED (JP) 2024-05-09 US claimed
EP-4286393-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE Daiichi Sankyo Company, Limited (JP) 2023-12-06 EP claimed
CN-116867795-A Novel method for producing antibody-immunostimulant conjugate 第一三共株式会社 2023-10-10 CN claimed
CN-115354036-B Stabilizer of reverse transcriptase 北京纳捷诊断试剂有限公司 2023-03-24 CN claimed
CN-115354036-A Stabilizer of reverse transcriptase 北京纳捷诊断试剂有限公司 2022-11-18 CN claimed
WO-2022163846-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE 第一三共株式会社 2022-08-04 WO claimed
EP-3156411-B1 ARTIFICIAL CATALYST SYSTEM CAPABLE OF SUBSTITUTING FOR IN VIVO ACYLATION FUNCTION UNIV TOKYO (JP) 2021-03-03 EP claimed
EP-3156411-A1 ARTIFICIAL CATALYST SYSTEM CAPABLE OF SUBSTITUTING FOR IN VIVO ACYLATION FUNCTION The University of Tokyo (JP) 2017-04-19 EP claimed
US-20170008927-A1 ARTIFICIAL CATALYST SYSTEM SUBSTITUTABLE FOR IN VIVO ACYLATION FUNCTION THE UNIVERSITY OF TOKYO (JP) 2017-01-12 US claimed
JP-2256659-A None JP disclosed
US-20240150390-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE DAIICHI SANKYO COMPANY, LIMITED (JP) 2024-05-09 US disclosed
WO-2024024935-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE HAVING ANTINEOPLASTIC EFFECT 第一三共株式会社 2024-02-01 WO disclosed
EP-4286393-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE Daiichi Sankyo Company, Limited (JP) 2023-12-06 EP disclosed
CN-116867795-A Novel method for producing antibody-immunostimulant conjugate 第一三共株式会社 2023-10-10 CN disclosed
US-20020006960-A1 Process for the preparation fo 4,5-diamino shikimic acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 2002-01-17 US disclosed
EP-1127872-A1 Tamiflu via Diels-Alder F. HOFFMANN-LA ROCHE AG (CH) 2001-08-29 EP disclosed
EP-1059283-A1 Process for preparing neuraminidase inhibitor ro-64-0796 F. HOFFMANN-LA ROCHE AG (CH) 2000-12-13 EP disclosed
US-5767296-A TAXOL DERIVATIVES; ANTITUMOR AND ANTICARCINOGENIC AGENTS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-06-16 US disclosed
EP-0764643-A1 DEACETOXYTAXOL DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-03-26 EP disclosed
JP-H02256659-A DIACYLAMIDE COMPOUND AND PRODUCTION OF AMIDE KIKUKAWA YASUO 1990-10-17 JP disclosed